99% Savings - Buy Just @1 Rs X
Olkem 40 H Tablet (14) is a prescription medicine that is available as a Tablet. Olkem 40 H Tablet (14) also has some secondary and off-label uses. These are listed below.
The right dosage of Olkem 40 H Tablet (14) depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Olkem 40 H Tablet (14) are Upper respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Olkem 40 H Tablet (14) as well, which are listed below. Usually, these side effects of Olkem 40 H Tablet (14) go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olkem 40 H Tablet (14) is Severe for pregnant women and Mild for women who are breastfeeding. Warnings related to Olkem 40 H Tablet (14)'s effects on the liver, heart and kidney, if any, have been listed below.
Olkem 40 H Tablet (14) is contraindicated in people with pre-existing medical conditions like Asthma, Allergy, Kidney Disease as it can result in adverse effects. Other contraindications of Olkem 40 H Tablet (14) have been discussed in the sections ahead.
Drug interactions for Olkem 40 H Tablet (14) have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Olkem 40 H Tablet (14) is not safe while driving, and is not addiction.
Olkem 40 H Tablet (14) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Olkem 40 H Tablet (14) safe for pregnant women?
Olkem H should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olkem 40 H Tablet (14) safe during breastfeeding?
Side effects of Olkem H on breastfeeding women are very mild.
What is the effect of Olkem 40 H Tablet (14) on the Kidneys?
Olkem H rarely affects the kidneys.
What is the effect of Olkem 40 H Tablet (14) on the Liver?
Olkem H has very mild side effects on the liver.
What is the effect of Olkem 40 H Tablet (14) on the Heart?
Olkem H is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Olkem 40 H Tablet (14) unless your doctor advises you to do so -
Is this Olkem 40 H Tablet (14) habit forming or addictive?
No, there is no any evidence that Olkem 40 H Tablet (14) is addictive.
Interaction between Food and Olkem 40 H Tablet (14)
Taking Olkem 40 H Tablet (14) with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olkem 40 H Tablet (14)
Taking alcohol with Olkem 40 H Tablet (14) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173